The Claim
Omega-3 fatty acid supplementation at 2000 mg/day for 90 days has no significant effect on HDL-C, total cholesterol, or hsCRP levels in adults, regardless of PPARG polymorphism status, indicating that its lipid-modifying effects are specific to LDL-C and triglycerides and not mediated by systemic inflammation or broad changes in the lipid profile.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking 2000 mg of omega-3s daily for three months doesn’t change your good cholesterol, total cholesterol, or inflammation markers — so if it helps lower bad cholesterol and triglycerides, it’s not because it’s reducing overall inflammation or affecting all types of fats in your blood.
See the scientific wording
Omega-3 fatty acid supplementation at 2000 mg/day for 90 days does not significantly alter HDL-C, total cholesterol, or hsCRP levels in adults with or without PPARG polymorphisms, indicating that the lipid-lowering effect is specific to LDL-C and triglycerides and not mediated by systemic inflammation or broad lipid profile changes.
What the research says
1 studyTaking 2000 mg of omega-3 daily for 90 days lowered bad fats (LDL and triglycerides) in some people but didn’t change good cholesterol or inflammation markers—so it’s not helping by reducing overall inflammation or boosting all cholesterol types.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.